Effects of two functionally important SLCO1B1 gene polymorphisms on pharmacokinetics of atorvastatin
Pakistan Journal of Pharmaceutical Sciences. 2017; 30 (4): 1363-1370
Dans Anglais
| IMEMR
| ID: emr-189707
ABSTRACT
Organic anion transporter polypeptide 1B1 [OATP1B1] encoded by [SLCO1B1] gene, an uptake transporter involved in the transport of drugs and endogenous compounds and located in hepatocyte sinusoidal membrane. Objective of study was to investigate the effects of two functionally significant SNPs [388A>G and 521T>C] and their respective genotypes of SLCO1B1 gene encoding OATP1B1 on the pharmiacokinetics of atorvastatin. A total of 100 subjects divided into 6 groups as per their genotype profile were recruited. A single dose of 80mg atorvastatin was orally administered and plasma concentration measured up to 48 hours. The 388A>G and 521T>C genotypes were significantly associated with each other when compared for AUC and C[MAX] but exhibited no significant variations in T[MAX] and ti/[2]. 521 SNP is rather more strongly associated with altered pharmacokinetics of atorvastatin when compared with the 388 SNP, though the homozygous bi-allelic variant of 388 SNP also exhibited a fairly significant variation along with homozygous bi-allelic variant of 521 SNP. The inter-individual variation in pharmacokinetics can be explained by SLCO1B1 polymorphism
Recherche sur Google
Indice:
Méditerranée orientale
Sujet Principal:
Polymorphisme génétique
/
Réaction de polymérisation en chaîne
/
Polymorphisme de nucléotide simple
/
Transporteurs d'anions organiques
/
Polypeptide C de transport d'anions organiques
Limites du sujet:
Humains
langue:
Anglais
Texte intégral:
Pak. J. Pharm. Sci.
Année:
2017
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS